View in EDS

Comparative effectiveness of HMA with venetoclax vs intensive chemotherapy in AML with very high-risk cytogenetics.

Saved in:
Bibliographic Details
Title: Comparative effectiveness of HMA with venetoclax vs intensive chemotherapy in AML with very high-risk cytogenetics.
Authors: Aguirre LE; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.; Section of Medical Oncology and Hematology, Department of Internal Medicine, Yale School of Medicine, New Haven, CT.; Harvard T.H. Chan School of Public Health, Boston, MA., Bewersdorf JP; Section of Medical Oncology and Hematology, Department of Internal Medicine, Yale School of Medicine, New Haven, CT., Liu Y; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA., Shallis RM; Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL., Boussi L; Memorial Sloan Kettering Cancer Center, New York, NY., Zucenka A; Department of Hematology and Oncology, Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, Vilnius, Lithuania., Garciaz S; Centre de Recherche en Cancérologie de Marseille, Institut Paoli-Calmettes, Aix-Marseille Université, INSERM, Centre National de la Recherche Scientifique, Marseille, France., Bystrom RP; Division of Hematologic Malignancies and Cellular Therapy, Duke Blood Cancer Center, Durham, NC., DeAngelo DJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Stone RM; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Luskin MR; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Garcia JS; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Winer ES; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Ling K; Section of Medical Oncology and Hematology, Department of Internal Medicine, Yale School of Medicine, New Haven, CT., Chen EC; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Wadleigh M; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Berton G; Centre de Recherche en Cancérologie de Marseille, Institut Paoli-Calmettes, Aix-Marseille Université, INSERM, Centre National de la Recherche Scientifique, Marseille, France., Stein EM; Memorial Sloan Kettering Cancer Center, New York, NY., Goldberg AD; Memorial Sloan Kettering Cancer Center, New York, NY., Mendez L; Section of Medical Oncology and Hematology, Department of Internal Medicine, Yale School of Medicine, New Haven, CT., Zeidan AM; Section of Medical Oncology and Hematology, Department of Internal Medicine, Yale School of Medicine, New Haven, CT., Sallman DA; Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL., Shimony S; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Stahl M; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.; Section of Medical Oncology and Hematology, Department of Internal Medicine, Yale School of Medicine, New Haven, CT.
Source: Blood neoplasia [Blood Neoplasia] 2026 Jan 28; Vol. 3 (2), pp. 100201. Date of Electronic Publication: 2026 Jan 28 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Elsevier, Inc Country of Publication: United States NLM ID: 9918841988906676 Publication Model: eCollection Cited Medium: Internet ISSN: 2950-3280 (Electronic) Linking ISSN: 29503280 NLM ISO Abbreviation: Blood Neoplasia Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41859348
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Comparative effectiveness of HMA with venetoclax vs intensive chemotherapy in AML with very high-risk cytogenetics.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Aguirre+LE%22">Aguirre LE</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.; Section of Medical Oncology and Hematology, Department of Internal Medicine, Yale School of Medicine, New Haven, CT.; Harvard T.H. Chan School of Public Health, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Bewersdorf+JP%22">Bewersdorf JP</searchLink>; Section of Medical Oncology and Hematology, Department of Internal Medicine, Yale School of Medicine, New Haven, CT.<br /><searchLink fieldCode="AU" term="%22Liu+Y%22">Liu Y</searchLink>; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Shallis+RM%22">Shallis RM</searchLink>; Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.<br /><searchLink fieldCode="AU" term="%22Boussi+L%22">Boussi L</searchLink>; Memorial Sloan Kettering Cancer Center, New York, NY.<br /><searchLink fieldCode="AU" term="%22Zucenka+A%22">Zucenka A</searchLink>; Department of Hematology and Oncology, Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, Vilnius, Lithuania.<br /><searchLink fieldCode="AU" term="%22Garciaz+S%22">Garciaz S</searchLink>; Centre de Recherche en Cancérologie de Marseille, Institut Paoli-Calmettes, Aix-Marseille Université, INSERM, Centre National de la Recherche Scientifique, Marseille, France.<br /><searchLink fieldCode="AU" term="%22Bystrom+RP%22">Bystrom RP</searchLink>; Division of Hematologic Malignancies and Cellular Therapy, Duke Blood Cancer Center, Durham, NC.<br /><searchLink fieldCode="AU" term="%22DeAngelo+DJ%22">DeAngelo DJ</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Stone+RM%22">Stone RM</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Luskin+MR%22">Luskin MR</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Garcia+JS%22">Garcia JS</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Winer+ES%22">Winer ES</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Ling+K%22">Ling K</searchLink>; Section of Medical Oncology and Hematology, Department of Internal Medicine, Yale School of Medicine, New Haven, CT.<br /><searchLink fieldCode="AU" term="%22Chen+EC%22">Chen EC</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Wadleigh+M%22">Wadleigh M</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Berton+G%22">Berton G</searchLink>; Centre de Recherche en Cancérologie de Marseille, Institut Paoli-Calmettes, Aix-Marseille Université, INSERM, Centre National de la Recherche Scientifique, Marseille, France.<br /><searchLink fieldCode="AU" term="%22Stein+EM%22">Stein EM</searchLink>; Memorial Sloan Kettering Cancer Center, New York, NY.<br /><searchLink fieldCode="AU" term="%22Goldberg+AD%22">Goldberg AD</searchLink>; Memorial Sloan Kettering Cancer Center, New York, NY.<br /><searchLink fieldCode="AU" term="%22Mendez+L%22">Mendez L</searchLink>; Section of Medical Oncology and Hematology, Department of Internal Medicine, Yale School of Medicine, New Haven, CT.<br /><searchLink fieldCode="AU" term="%22Zeidan+AM%22">Zeidan AM</searchLink>; Section of Medical Oncology and Hematology, Department of Internal Medicine, Yale School of Medicine, New Haven, CT.<br /><searchLink fieldCode="AU" term="%22Sallman+DA%22">Sallman DA</searchLink>; Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.<br /><searchLink fieldCode="AU" term="%22Shimony+S%22">Shimony S</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Stahl+M%22">Stahl M</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.; Section of Medical Oncology and Hematology, Department of Internal Medicine, Yale School of Medicine, New Haven, CT.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229918841988906676%22">Blood neoplasia</searchLink> [Blood Neoplasia] 2026 Jan 28; Vol. 3 (2), pp. 100201. <i>Date of Electronic Publication: </i>2026 Jan 28 (<i>Print Publication: </i>2026).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%2C+Inc%22">Elsevier, Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9918841988906676 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2950-3280 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2229503280%22">29503280 </searchLink><i>NLM ISO Abbreviation: </i>Blood Neoplasia <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41859348
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.bneo.2026.100201
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 100201
    Titles:
      – TitleFull: Comparative effectiveness of HMA with venetoclax vs intensive chemotherapy in AML with very high-risk cytogenetics.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Aguirre LE
      – PersonEntity:
          Name:
            NameFull: Bewersdorf JP
      – PersonEntity:
          Name:
            NameFull: Liu Y
      – PersonEntity:
          Name:
            NameFull: Shallis RM
      – PersonEntity:
          Name:
            NameFull: Boussi L
      – PersonEntity:
          Name:
            NameFull: Zucenka A
      – PersonEntity:
          Name:
            NameFull: Garciaz S
      – PersonEntity:
          Name:
            NameFull: Bystrom RP
      – PersonEntity:
          Name:
            NameFull: DeAngelo DJ
      – PersonEntity:
          Name:
            NameFull: Stone RM
      – PersonEntity:
          Name:
            NameFull: Luskin MR
      – PersonEntity:
          Name:
            NameFull: Garcia JS
      – PersonEntity:
          Name:
            NameFull: Winer ES
      – PersonEntity:
          Name:
            NameFull: Ling K
      – PersonEntity:
          Name:
            NameFull: Chen EC
      – PersonEntity:
          Name:
            NameFull: Wadleigh M
      – PersonEntity:
          Name:
            NameFull: Berton G
      – PersonEntity:
          Name:
            NameFull: Stein EM
      – PersonEntity:
          Name:
            NameFull: Goldberg AD
      – PersonEntity:
          Name:
            NameFull: Mendez L
      – PersonEntity:
          Name:
            NameFull: Zeidan AM
      – PersonEntity:
          Name:
            NameFull: Sallman DA
      – PersonEntity:
          Name:
            NameFull: Shimony S
      – PersonEntity:
          Name:
            NameFull: Stahl M
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 28
              M: 01
              Text: 2026 Jan 28
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 2950-3280
          Numbering:
            – Type: volume
              Value: 3
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: Blood neoplasia
              Type: main
ResultId 1